EXACT Therapeutics AS (DE:56F) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EXACT Therapeutics, a precision medicine company, has strengthened its board with the addition of Jonathan Allis and Flavien Daloz, both bringing extensive experience from the pharmaceutical and med-tech industries. This move aligns with the company’s strategy to advance its development pipeline and internationalize its operations, following a significant investment from GE Medical Holdings AB.
For further insights into DE:56F stock, check out TipRanks’ Stock Analysis page.